Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury

Junling Gao, Donald Prough, David J. McAdoo, James J. Grady, Margaret O. Parsley, Long Ma, Yevgeniya I. Tarensenko, Ping Wu

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Traumatic brain injury (TBI) often produces cognitive impairments by primary or secondary neuronal loss. Stem cells are a potential tool to treat TBI. However, most previous studies using rodent stem or progenitor cells failed to correlate cell grafting and cognitive improvement. Furthermore, the efficacy of fetal human neural stem cells (hNSCs) for ameliorating TBI cognitive dysfunction is undetermined. This study therefore characterized phenotypic differentiation, neurotrophic factor expression and release and functional outcome of grafting hNSCs into TBI rat brains. Adult Sprague-Dawley rats underwent a moderate parasagittal fluid percussion TBI followed by ipsilateral hippocampal transplantation of hNSCs or vehicle 1 day post-injury. Prior to grafting, hNSCs were treated in vitro for 7 days with our previously developed priming procedure. Significant spatial learning and memory improvements were detected by the Morris water maze (MWM) test in rats 10 days after receiving hNSC grafts. Morphological analyses revealed that hNSCs survived and differentiated mainly into neurons in the injured hippocampus at 2 weeks after grafting. Furthermore, hNSCs expressed and released glial-cell-line-derived neurotrophic factor (GDNF) in vitro and when grafted in vivo, as detected by RT-PCR, immunostaining, microdialysis and ELISA. This is the first direct demonstration of the release of a neurotrophic factor in conjunction with stem cell grafting. In conclusion, human fetal neural stem cell grafts improved cognitive function of rats with acute TBI. Grafted cells survived and differentiated into neurons and expressed and released GNDF in vivo, which may help protect host cells from secondary damage and aid host regeneration.

Original languageEnglish (US)
Pages (from-to)281-292
Number of pages12
JournalExperimental Neurology
Volume201
Issue number2
DOIs
StatePublished - Oct 2006

Fingerprint

Fetal Stem Cells
Neural Stem Cells
Cognition
Transplantation
Stem Cells
Nerve Growth Factors
Percussion
Transplants
Glial Cell Line-Derived Neurotrophic Factor
Neurons
Traumatic Brain Injury
Microdialysis
Brain Injuries
Sprague Dawley Rats
Regeneration
Rodentia
Hippocampus
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction

Keywords

  • Cognitive function
  • Glial-cell-line-derived neurotrophic factor
  • Hippocampus
  • Neural stem cell
  • Transplantation
  • Traumatic brain injury

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. / Gao, Junling; Prough, Donald; McAdoo, David J.; Grady, James J.; Parsley, Margaret O.; Ma, Long; Tarensenko, Yevgeniya I.; Wu, Ping.

In: Experimental Neurology, Vol. 201, No. 2, 10.2006, p. 281-292.

Research output: Contribution to journalArticle

Gao, Junling ; Prough, Donald ; McAdoo, David J. ; Grady, James J. ; Parsley, Margaret O. ; Ma, Long ; Tarensenko, Yevgeniya I. ; Wu, Ping. / Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. In: Experimental Neurology. 2006 ; Vol. 201, No. 2. pp. 281-292.
@article{c35805e29bc34c9f98c4189ae7001ac9,
title = "Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury",
abstract = "Traumatic brain injury (TBI) often produces cognitive impairments by primary or secondary neuronal loss. Stem cells are a potential tool to treat TBI. However, most previous studies using rodent stem or progenitor cells failed to correlate cell grafting and cognitive improvement. Furthermore, the efficacy of fetal human neural stem cells (hNSCs) for ameliorating TBI cognitive dysfunction is undetermined. This study therefore characterized phenotypic differentiation, neurotrophic factor expression and release and functional outcome of grafting hNSCs into TBI rat brains. Adult Sprague-Dawley rats underwent a moderate parasagittal fluid percussion TBI followed by ipsilateral hippocampal transplantation of hNSCs or vehicle 1 day post-injury. Prior to grafting, hNSCs were treated in vitro for 7 days with our previously developed priming procedure. Significant spatial learning and memory improvements were detected by the Morris water maze (MWM) test in rats 10 days after receiving hNSC grafts. Morphological analyses revealed that hNSCs survived and differentiated mainly into neurons in the injured hippocampus at 2 weeks after grafting. Furthermore, hNSCs expressed and released glial-cell-line-derived neurotrophic factor (GDNF) in vitro and when grafted in vivo, as detected by RT-PCR, immunostaining, microdialysis and ELISA. This is the first direct demonstration of the release of a neurotrophic factor in conjunction with stem cell grafting. In conclusion, human fetal neural stem cell grafts improved cognitive function of rats with acute TBI. Grafted cells survived and differentiated into neurons and expressed and released GNDF in vivo, which may help protect host cells from secondary damage and aid host regeneration.",
keywords = "Cognitive function, Glial-cell-line-derived neurotrophic factor, Hippocampus, Neural stem cell, Transplantation, Traumatic brain injury",
author = "Junling Gao and Donald Prough and McAdoo, {David J.} and Grady, {James J.} and Parsley, {Margaret O.} and Long Ma and Tarensenko, {Yevgeniya I.} and Ping Wu",
year = "2006",
month = "10",
doi = "10.1016/j.expneurol.2006.04.039",
language = "English (US)",
volume = "201",
pages = "281--292",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury

AU - Gao, Junling

AU - Prough, Donald

AU - McAdoo, David J.

AU - Grady, James J.

AU - Parsley, Margaret O.

AU - Ma, Long

AU - Tarensenko, Yevgeniya I.

AU - Wu, Ping

PY - 2006/10

Y1 - 2006/10

N2 - Traumatic brain injury (TBI) often produces cognitive impairments by primary or secondary neuronal loss. Stem cells are a potential tool to treat TBI. However, most previous studies using rodent stem or progenitor cells failed to correlate cell grafting and cognitive improvement. Furthermore, the efficacy of fetal human neural stem cells (hNSCs) for ameliorating TBI cognitive dysfunction is undetermined. This study therefore characterized phenotypic differentiation, neurotrophic factor expression and release and functional outcome of grafting hNSCs into TBI rat brains. Adult Sprague-Dawley rats underwent a moderate parasagittal fluid percussion TBI followed by ipsilateral hippocampal transplantation of hNSCs or vehicle 1 day post-injury. Prior to grafting, hNSCs were treated in vitro for 7 days with our previously developed priming procedure. Significant spatial learning and memory improvements were detected by the Morris water maze (MWM) test in rats 10 days after receiving hNSC grafts. Morphological analyses revealed that hNSCs survived and differentiated mainly into neurons in the injured hippocampus at 2 weeks after grafting. Furthermore, hNSCs expressed and released glial-cell-line-derived neurotrophic factor (GDNF) in vitro and when grafted in vivo, as detected by RT-PCR, immunostaining, microdialysis and ELISA. This is the first direct demonstration of the release of a neurotrophic factor in conjunction with stem cell grafting. In conclusion, human fetal neural stem cell grafts improved cognitive function of rats with acute TBI. Grafted cells survived and differentiated into neurons and expressed and released GNDF in vivo, which may help protect host cells from secondary damage and aid host regeneration.

AB - Traumatic brain injury (TBI) often produces cognitive impairments by primary or secondary neuronal loss. Stem cells are a potential tool to treat TBI. However, most previous studies using rodent stem or progenitor cells failed to correlate cell grafting and cognitive improvement. Furthermore, the efficacy of fetal human neural stem cells (hNSCs) for ameliorating TBI cognitive dysfunction is undetermined. This study therefore characterized phenotypic differentiation, neurotrophic factor expression and release and functional outcome of grafting hNSCs into TBI rat brains. Adult Sprague-Dawley rats underwent a moderate parasagittal fluid percussion TBI followed by ipsilateral hippocampal transplantation of hNSCs or vehicle 1 day post-injury. Prior to grafting, hNSCs were treated in vitro for 7 days with our previously developed priming procedure. Significant spatial learning and memory improvements were detected by the Morris water maze (MWM) test in rats 10 days after receiving hNSC grafts. Morphological analyses revealed that hNSCs survived and differentiated mainly into neurons in the injured hippocampus at 2 weeks after grafting. Furthermore, hNSCs expressed and released glial-cell-line-derived neurotrophic factor (GDNF) in vitro and when grafted in vivo, as detected by RT-PCR, immunostaining, microdialysis and ELISA. This is the first direct demonstration of the release of a neurotrophic factor in conjunction with stem cell grafting. In conclusion, human fetal neural stem cell grafts improved cognitive function of rats with acute TBI. Grafted cells survived and differentiated into neurons and expressed and released GNDF in vivo, which may help protect host cells from secondary damage and aid host regeneration.

KW - Cognitive function

KW - Glial-cell-line-derived neurotrophic factor

KW - Hippocampus

KW - Neural stem cell

KW - Transplantation

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=33748423523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748423523&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2006.04.039

DO - 10.1016/j.expneurol.2006.04.039

M3 - Article

VL - 201

SP - 281

EP - 292

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -